cancer clinical trials in birmingham, AL
1200.36.0016 Boehringer Ingelheim Investigational Site
Birmingham, Alabama Glioma
|
University of Alabama at Birmingham
Trial Locations University of Alabama at Birmingham Children's Hospital of Alabama Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Sickle Cell Disease
|
University of Alabama
Birmingham, Alabama Osteosarcoma
|
Pfizer Investigational Site
Birmingham, Alabama 35205 Non-small Cell Lung Cancer
|
Brachytherapy Site: Urology Centers of Alabama
Birmingham, Alabama 35209 Prostate Cancer
|
University of Alabama at Birmingham
Trial Locations University of Alabama at Birmingham Children's Hospital of Alabama Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Tuberous Sclerosis, Subependymal Giant Cell Astrocytoma
|
Novartis Investigative Site
Birmingham, Alabama 35294 Tuberous Sclerosis Complex (TSC), Lymphangioleiomyomatosis (LAM)
|
Children's Hospital of Alabama
Birmingham, Alabama 35233 Juvenile Idiopathic Arthritis
|
GSK Investigational Site
Birmingham, Alabama 35209 Melanoma
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
|
Site Reference ID/Investigator# 18801
Birmingham, Alabama 35243 Melanoma, Metastatic Melanoma, Skin Cancer
|
UAB Comprehensive Cancer Center
Birmingham, Alabama 35294 Endometrial Cancer, Fatigue, Neurotoxicity
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Head and Neck Cancer, Pharyngeal Cancer, Laryngeal Cancer
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
|
University of Alabama
Birmingham, Alabama Rheumatoid Arthritis
|
UAB Comprenhensive Cancer Center at University of Alabama
Birmingham, Alabama 35294 Metastatic Pancreatic Cancer
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Disease, Hodgkin
|
GSK Investigational Site
Birmingham, Alabama 35209 Neoplasms, Breast
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Ovarian Cancer
|
The University of Alabama at Birmingham
Birmingham, Alabama 35294 Neurofibromatosis Type 1
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Small Cell Lung Cancer, Extensive Stage Lung Cancer, Chemonaive
|
UAB Comprehensive Cancer Center
Birmingham, Alabama 35294 Lung Cancer
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Malignant Melanoma
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin
|
UAB Comprehensive Cancer Center
Birmingham, Alabama 35294 Leukemia
|
Pfizer Investigational Site
Birmingham, Alabama 35205 Lymphoma
|
UAB Comprehensive Cancer Center
Birmingham, Alabama 35294 Leukemia, Lymphoma
|
Pfizer Investigational Site
Birmingham, Alabama 35205 Breast Cancer
|
Birmingham, Alabama 35294 Prostate Cancer
|
Birmingham Hematology and Oncology
Trial Locations Birmingham Hematology and Oncology Birmingham Hematology and Oncology - Pilot Birmingham Hematology and Oncology - Princeton Birmingham Hematology and Oncology - Montclair Birmingham Hematology and Oncology - Brookwood Breast Cancer
|
UAB Comprehensive Cancer Center
Birmingham, Alabama 35294 Leukemia, Lymphoma
|
Children's Hospital of Alabama at University of Alabama at Birmingham
Birmingham, Alabama 35233 Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
|
Children's Hospital of Alabama at University of Alabama at Birmingham
Birmingham, Alabama 35233 Kidney Cancer, Nonneoplastic Condition
|
Children's Hospital of Alabama at University of Alabama at Birmingham
Birmingham, Alabama 35233 Cancer
|
Children's Hospital of Alabama at University of Alabama at Birmingham
Birmingham, Alabama 35233 Sarcoma
|
Children's Hospital of Alabama at University of Alabama at Birmingham
Birmingham, Alabama 35233 Sarcoma
|
Children's Hospital of Alabama at University of Alabama at Birmingham
Birmingham, Alabama 35233 Lymphoma
|
University of Alabama at Birmingham/ Kirklin Clinic Comprehensive CancerCenter (1)
Birmingham, Alabama 35294-0006 Renal Cell Carcinoma
|
Children's Hospital of Alabama at University of Alabama at Birmingham
Birmingham, Alabama 35233 Neuroblastoma
|
University of Alabama, Birmingham
Birmingham, Alabama 35233 Head and Neck Squamous Cell Carcinoma
|
ImClone Investigational Site
Birmingham, Alabama 35233 Non-Small Cell Lung Cancer
|
University of Alabama at Birmingham
Trial Locations University of Alabama at Birmingham Children's Hospital of Alabama Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Breast Cancer
|
Birmingham, Alabama 35294 Pain, Burning, Pain, Crushing, Pain, Migratory, Pain, Radiating, Pain, Splitting
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Breast Cancer
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor, Childhood Central Nervous System Germ Cell Tumor, Childhood Central Nervous System Germinoma, Childhood Central Nervous System Mixed Germ Cell Tumor, Childhood Central Nervous System Teratoma, Childhood Central Nervous System Yolk Sac Tumor, Metastatic Childhood Soft Tissue Sarcoma, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Central Nervous System Embryonal Tumor, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Childhood Visual Pathway Glioma, Unspecified Childhood Solid Tumor, Protocol Specific
|
University of Alabama
Birmingham, Alabama Breast Cancer
|
Pfizer Investigational Site
Birmingham, Alabama 35205 Carcinoma, Non-Small-Cell Lung
|
UAB Comprehensive Cancer Center
Birmingham, Alabama 35294 Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Breast Cancer
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
|
UAB Comprehensive Cancer Center
Birmingham, Alabama 35294 Endometrial Cancer
|
Birmingham, Alabama 35294 Glioblastoma
|
University of Alabama at Birmingham
Trial Locations University of Alabama at Birmingham Children's Hospital of Alabama Diffuse Hyperplastic Perilobar Nephroblastomatosis, Rhabdoid Tumor of the Kidney, Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor, Stage IV Wilms Tumor, Stage V Wilms Tumor
|